Podcast Episode

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Listen Free in iTunes 

Listen Free on Stitcher Radio

Dr. Al Robichaud is Chief Scientific Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Al received his B.S. in chemistry from Rensselaer Polytechnic Institute. He worked as a staff chemist at FMC Corporation for about two years before returning to school to earn his PhD in Organic Chemistry from the University of California, Irvine. Al next conducted research as an American Cancer Society postdoctoral fellow in organic chemistry at Colorado State University. Before joining the team at Sage Therapeutics, Al held positions at Merck Pharma, DuPont Merck Pharma, DuPont Pharmaceuticals, Bristol-Myers Squibb, Wyeth Pharmaceuticals, and Lundbeck Research. In our interview, Al tells us more about his life and science.

[Read more…] about 510: Dr. Al Robichaud: Creating New Compounds to Treat Central Nervous System Disorders

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Listen Free in iTunes 

Listen Free on Stitcher Radio

Dr. Christine Drea is the Earl D. McLean Professor of Evolutionary Anthropology, as well as Professor in the Department of Biology, the University Program in Ecology, and the Duke Institute for Brain Sciences at Duke University. Christine completed her undergraduate training in zoology at the University of Maryland College Park. She earned her M.A. and Ph.D. degrees in psychobiology from Emory University. Afterwards, Christine conducted postdoctoral research in physiology at the Morehouse School of Medicine, and subsequently she was awarded a National Institutes of Health National Research Service Award postdoctoral fellowship in psychology to conduct research at the University of California, Berkeley. Next, Christine served as a lecturer at UC, Berkeley before joining the faculty at Duke University. At Duke, she has been awarded the Thomas Langford Lectureship Award for the appeal of her research to an interdisciplinary audience and her embodiment of Langford’s dedication to teaching, research, and service. In our interview, Christine shares more about her life and science.

[Read more…] about 509: Dr. Christine Drea: Studying Social Behavior, Reproduction, and Health in Female-Dominant Species

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Listen Free in iTunes 

Listen Free on Stitcher Radio

Dr. Paul Cannon is the Parkinson’s Disease Program Manager at 23andMe. Paul received his Master’s degree in Natural Sciences from Christ’s College in Cambridge and his PhD in Medical Sciences from the University of Calgary. Afterwards, he worked as a Research Scientist at Syntex. Next, Paul spent nearly 15 years in various roles at Roche Pharmaceuticals and Genentech. He worked as a Senior Consultant for Tynan Consulting for about four years before joining the team at 23andMe. In our interview, Paul tells us more about his life and science.

[Read more…] about 508: Dr. Paul Cannon: Investigating Genetic Profiles and Phenotypes of People with Parkinson’s Disease

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Listen Free in iTunes 

Listen Free on Stitcher Radio

Dr. Cori Richards-Zawacki is an Associate Professor in the Department of Biological Sciences and Director of the Pymatuning Lab of Ecology at the University of Pittsburgh. Cori received her Bachelor’s degree in engineering and biology as well as her PhD in ecology and evolutionary biology both from the University of Michigan. She conducted postdoctoral research at the Smithsonian Institute and the University of California, Berkeley. Cori next served on the faculty at Tulane University prior to joining the faculty at the University of Pittsburgh in 2015. In our interview, Cori shares more about her life and science.

[Read more…] about 507: Dr. Cori Richards-Zawacki: Investigating How Frogs are Impacted by Climate Change, Fungal Disease, and Selection Pressures

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS

Listen Free in iTunes 

Listen Free on Stitcher Radio

Dr. Jim Doherty is Chief Research Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Jim received his B.A. in biology from the University of Delaware and his Ph.D. in neuroscience from Georgetown University. Next, he conducted postdoctoral research at Emory University Medical School and subsequently served on the faculty at Emory for about two years. Prior to joining the team at Sage in 2014, Jim worked for about eleven years at AstraZeneca Pharmaceuticals. In our interview Jim shares more about his life and science.

[Read more…] about 506: Dr. Jim Doherty: Sage Scientist Developing New Drugs for Depression and Other Neurological Diseases